RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Enzo Biochem Stock

Enzo Biochem P/S 2025

Enzo Biochem P/S

1.91

Ticker

ENZ

ISIN

US2941001024

WKN

865607

As of Jan 29, 2025, Enzo Biochem's P/S ratio stood at 1.91, a -44.96% change from the 3.47 P/S ratio recorded in the previous year.

The Enzo Biochem P/S history

Enzo Biochem Aktienanalyse

What does Enzo Biochem do?

Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Enzo Biochem's P/S Ratio

Enzo Biochem's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Enzo Biochem's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Enzo Biochem's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Enzo Biochem’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Enzo Biochem stock

What is the price-to-earnings ratio of Enzo Biochem?

The price-earnings ratio of Enzo Biochem is currently 1.91.

How has the price-earnings ratio of Enzo Biochem changed compared to last year?

The price-to-earnings ratio of Enzo Biochem has increased by -44.96% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Enzo Biochem high compared to other companies?

Yes, the price-to-earnings ratio of Enzo Biochem is high compared to other companies.

How does an increase in the price-earnings ratio of Enzo Biochem affect the company?

An increase in the price-earnings ratio of Enzo Biochem would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Enzo Biochem affect the company?

A decrease in the price-earnings ratio of Enzo Biochem would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Enzo Biochem?

Some factors that influence the price-earnings ratio of Enzo Biochem are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Enzo Biochem pay?

Over the past 12 months, Enzo Biochem paid a dividend of 0.1 USD . This corresponds to a dividend yield of about 15.69 %. For the coming 12 months, Enzo Biochem is expected to pay a dividend of 0.1 USD.

What is the dividend yield of Enzo Biochem?

The current dividend yield of Enzo Biochem is 15.69 %.

When does Enzo Biochem pay dividends?

Enzo Biochem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzo Biochem?

Enzo Biochem paid dividends every year for the past 1 years.

What is the dividend of Enzo Biochem?

For the upcoming 12 months, dividends amounting to 0.1 USD are expected. This corresponds to a dividend yield of 15.69 %.

In which sector is Enzo Biochem located?

Enzo Biochem is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzo Biochem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzo Biochem from 12/2/2024 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Enzo Biochem pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Enzo Biochem in the year 2024?

In the year 2024, Enzo Biochem distributed 0 USD as dividends.

In which currency does Enzo Biochem pay out the dividend?

The dividends of Enzo Biochem are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Enzo Biochem stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Enzo Biochem

Our stock analysis for Enzo Biochem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzo Biochem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.